Back to Search
Start Over
Supplementary Information from Eribulin Plus Pembrolizumab in Patients with Metastatic Triple-Negative Breast Cancer (ENHANCE 1): A Phase Ib/II Study
- Publication Year :
- 2023
- Publisher :
- American Association for Cancer Research (AACR), 2023.
-
Abstract
- Supplementary Information
Details
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....2651cad31791dcbd5d9c34941f502a4e
- Full Text :
- https://doi.org/10.1158/1078-0432.22478769.v1